Evidence map›Paper›PMID 37023389›Full record

ArticleJournal of natural products2023

Natural Cannabichromene (CBC) Shows Distinct Scalemicity Grades and Enantiomeric Dominance in

Andrea Calcaterra, Gabriele Cianfoni, Carola Tortora, Simone Manetto, Giulio Grassi, Bruno Botta, Francesco Gasparrini, Giulia Mazzoccanti, Giovanni Appendino

Open access · hybridAbstract read
In one paragraph

Article in Journal of natural products, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
7.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. (+)-Trans-Cannabidiol Is an Agonist at Human CBPharmacology research & perspectives · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Andrea CalcaterraDipartimento di Chimica e Tecnologie del Farmaco, Sapienza Università di Roma, p.le A. Moro 5, 00185 Rome, Italy.ORCID 0000-0001-7036-6620
Gabriele CianfoniDipartimento di Chimica e Tecnologie del Farmaco, Sapienza Università di Roma, p.le A. Moro 5, 00185 Rome, Italy.ORCID 0000-0002-6969-2071
Carola TortoraDipartimento di Chimica e Tecnologie del Farmaco, Sapienza Università di Roma, p.le A. Moro 5, 00185 Rome, Italy.
Simone ManettoDipartimento di Chimica e Tecnologie del Farmaco, Sapienza Università di Roma, p.le A. Moro 5, 00185 Rome, Italy.
Giulio GrassiCanvasalus Research, Via Cristoforo Colombo 64, 35043 Monselice (PD), Italy.
Bruno BottaDipartimento di Chimica e Tecnologie del Farmaco, Sapienza Università di Roma, p.le A. Moro 5, 00185 Rome, Italy.ORCID 0000-0001-8707-4333
Francesco GasparriniDipartimento di Chimica e Tecnologie del Farmaco, Sapienza Università di Roma, p.le A. Moro 5, 00185 Rome, Italy.ORCID 0000-0003-0970-2917
Giulia MazzoccantiDipartimento di Chimica e Tecnologie del Farmaco, Sapienza Università di Roma, p.le A. Moro 5, 00185 Rome, Italy.ORCID 0000-0001-8655-524X
Giovanni AppendinoDipartimento di Scienze del Farmaco, Largo Donegani 2, 28100 Novara, Italy.ORCID 0000-0002-4170-9919
Sapienza University of Rome · ITItalian Institute of Technology · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cannabichromene (CBC,

Indexed as

CannabinoidsCannabisHallucinogensCannabinoid Receptor AgonistscannabichromeneCannabinoid Receptor AgonistsCannabinoidsHallucinogens

Identifiers

PMID37023389
PMCPMC10152484
OpenAlexW4362659603

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.